Mathes Company’s iShares Global Healthcare ETF IXJ Stock Holding History

Mathes Company’s Portfolio IXJ Stock Details IXJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,750	Closed	-$237K	–	127
2025 Q2	$237K	Hold	2,750	–	–	0.09%	116
2025 Q1	$251K	Sell	2,750 -1,200	-30%	-$109K	0.1%	113
2024 Q4	$340K	Hold	3,950	–	–	0.12%	100
2024 Q3	$388K	Hold	3,950	–	–	0.14%	101
2024 Q2	$367K	Hold	3,950	–	–	0.13%	99
2024 Q1	$368K	Hold	3,950	–	–	0.14%	105
2023 Q4	$343K	Hold	3,950	–	–	0.14%	105
2023 Q3	$326K	Hold	3,950	–	–	0.15%	105
2023 Q2	$336K	Buy	+3,950	New	+$337K	0.15%	102
2022 Q4	$335K	Hold	3,950	–	–	0.17%	100
2022 Q3	$298K	Hold	3,950	–	–	0.17%	98
2022 Q2	$321K	Hold	3,950	–	–	0.16%	102
2022 Q1	$346K	Hold	3,950	–	–	0.13%	103
2021 Q4	$357K	Hold	3,950	–	–	0.12%	106
2021 Q3	$331K	Hold	3,950	–	–	0.12%	105
2021 Q2	$328K	Sell	3,950 -500	-11%	-$40.4K	0.12%	103
2021 Q1	$343K	Hold	4,450	–	–	0.13%	102
2020 Q4	$340K	Hold	4,450	–	–	0.14%	100
2020 Q3	$320K	Hold	4,450	–	–	0.15%	93
2020 Q2	$306K	Hold	4,450	–	–	0.15%	92
2020 Q1	$271K	Hold	4,450	–	–	0.18%	88
2019 Q4	$306K	Hold	4,450	–	–	0.14%	103
2019 Q3	$272K	Sell	4,450 -6,200	-58%	-$379K	0.14%	106
2019 Q2	$657K	Hold	10,650	–	–	0.35%	73
2019 Q1	$651K	Hold	10,650	–	–	0.33%	77
2018 Q4	$603K	Hold	10,650	–	–	0.38%	69
2018 Q3	$671K	Buy	10,650 +400	+4%	+$24.2K	0.31%	76
2018 Q2	$579K	Buy	10,250 +1,050	+11%	+$59.2K	0.28%	84
2018 Q1	$512K	Hold	9,200	–	–	0.24%	86
2017 Q4	$518K	Hold	9,200	–	–	0.24%	86
2017 Q3	$517K	Buy	+9,200	New	+$506K	0.24%	89

Other funds holding IXJ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RBA

Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Mathes Company's IXJ Position: Q3 2025 in Review

Mathes Company sold out of iShares Global Healthcare ETF (IXJ) in Q3 2025, closing a stake of 2,750 shares — an estimated $237K sold.

Mathes Company first reported a position in IXJ in Q3 2017 and held it in 31 quarters. The position peaked at $671K in Q3 2018. 257 funds tracked by Wall St. Rank hold IXJ as of Q3 2025.

Mathes Company reported no remaining iShares Global Healthcare ETF position as of Q3 2025 after selling out during the quarter.
Mathes Company sold 2,750 iShares Global Healthcare ETF shares in Q3 2025, an estimated $237K.
Mathes Company first reported a position in iShares Global Healthcare ETF in Q3 2017 and held it in 31 quarters.
Mathes Company's iShares Global Healthcare ETF position peaked at $671K in Q3 2018.
257 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q3 2025.

Based on Mathes Company's 13F filing for Q3 2025, filed 12 Nov 2025.